This Article Full Text Full Text (PDF) CME: Take the exam for this article: CME 4: October, November, December 2003 Letters to the Editor: Submit a response Letters to the Editor: View responses Alert me when this article is cited Alert me when Letters to the Editor are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Reprints and Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, C.-J. Articles by Chen, H.-S. Search for Related Content PubMed PubMed Citation Articles by Wang, C.-J. Articles by Chen, H.-S. Social Bookmarking             What's this?

The Effect of Alendronate on Bone Mineral Density in the Distal Part of the Femur and Proximal Part of the Tibia After Total Knee Arthroplasty

¹ Department of Orthopedic Surgery (C.-J.W., J.-W.W., L.-H.W., C.-C. Hsu), Diagnostic Radiology (C.-C. Huang), and Surgery (H.-S.C.), Chang Gung Memorial Hospital, Kaohsiung Medical Center, 123 Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung, Taiwan 833. E-mail address for C.-J. Wang: w281211{at}adm.cgmh.org.tw

Investigation performed at the Departments of Orthopedic Surgery, Diagnostic Radiology, and Surgery, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Kaohsiung, Taiwan

In support of their research or preparation of this manuscript, one or more of the authors received grants or outside funding from Chang Gung Research Fund (CMRP 1026). None of the authors received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated. The local pharmaceutical distributor supplied the alendronate to the patients in this study free of charge.

Methods: Ninety-six women with an average age of seventy years who were undergoing total knee arthroplasty were randomly divided into two groups. Patients in the study group received oral alendronate at a dose of 10 mg/day for six months, whereas patients in the control group did not. The bone mineral density in the distal part of the femur and proximal part of the tibia was determined preoperatively and at six and twelve months postoperatively.

Results: In the control group, the bone mineral density showed significant decreases of 13.8% (p < 0.001) and 7.8% (p = 0.003) in the distal part of the femur and of 6.5% (p = 0.002) and 3.6% (p = 0.141) in the proximal part of the tibia at six and twelve months, respectively. In the study group, however, the bone mineral density showed significant increases of 10.0% (p = 0.010) and 1.9% (p = 0.049) in the distal part of the femur and of 9.4% (p < 0.001) and 5.4% (p = 0.032) in the proximal part of the tibia at six and twelve months, respectively. The overall differences in bone mineral density between the study and control groups were significant (p = 0.011 for the proximal part of the tibia, and p = 0.033 for the distal part of the femur).

Conclusions: We found significant postoperative decreases in bone mineral density in the distal part of the femur and proximal part of the tibia in women who had undergone total knee arthroplasty. Oral administration of alendronate for six months postoperatively significantly improved the bone mineral density. While the clinical benefits of alendronate after total knee arthroplasty remain unproven and the duration of follow-up in the present study was quite short, the improvement in bone mineral density may have a clinically important effect on prosthetic fixation and the rate of periprosthetic fractures after total knee arthroplasty.

Level of Evidence: Therapeutic study, Level I-1a (randomized controlled trial [significant difference]). See Instructions to Authors for a complete description of levels of evidence.

CiteULike    Connotea    Del.icio.us    Technorati    What's this?

This article has been cited by other articles:

				Y. Nakamura, K. Hayashi, S. Abu-Ali, M. Naito, and A. Fotovati Effect of Preoperative Combined Treatment with Alendronate and Calcitriol on Fixation of Hydroxyapatite-Coated Implants in Ovariectomized Rats J. Bone Joint Surg. Am., April 1, 2008; 90(4): 824 - 832. [Abstract] [Full Text] [PDF]

				D. A. Francis, D. L. Millis, and L. L. Head Bone and Lean Tissue Changes Following Cranial Cruciate Ligament Transection and Stifle Stabilization J. Am. Anim. Hosp. Assoc., March 1, 2006; 42(2): 127 - 135. [Abstract] [Full Text] [PDF]

				C.-J. Wang, J.-W. Wang, J.-Y. Ko, L.-H. Weng, and C.-C. Huang Three-Year Changes in Bone Mineral Density Around the Knee After a Six-Month Course of Oral Alendronate Following Total Knee Arthroplasty. A Prospective, Randomized Study J. Bone Joint Surg. Am., February 1, 2006; 88(2): 267 - 272. [Abstract] [Full Text] [PDF]

				C. D. Morris and T. A. Einhorn Bisphosphonates in Orthopaedic Surgery J. Bone Joint Surg. Am., July 1, 2005; 87(7): 1609 - 1618. [Abstract] [Full Text] [PDF]

				M. Bhandari, S. Bajammal, G. H. Guyatt, L. Griffith, J. W. Busse, H. Schunemann, and T. A. Einhorn Effect of Bisphosphonates on Periprosthetic Bone Mineral Density After Total Joint Arthroplasty. A Meta-Analysis J. Bone Joint Surg. Am., February 1, 2005; 87(2): 293 - 301. [Abstract] [Full Text] [PDF]

Letters to the Editor:

Stanford University Libraries' HighWire Press (TM) assists in the publication of JBJS Online.
Copyright © 2003 by The Journal of Bone and Joint Surgery, Inc. Online ISSN: 1535-1386.
The Journal of Bone and Joint Surgery®, JBJS®, JB&JS®, and eJBJS® are registered in the U.S. Patent and Trademark Office.